Evidence map›Paper›PMID 24535824›Full record

ArticleThe Journal of cell biology2014

CDK phosphorylation of SLD-2 is required for replication initiation and germline development in C. elegans.

Vincent Gaggioli, Eva Zeiser, David Rivers, Charles R Bradshaw, Julie Ahringer, Philip Zegerman

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Vincent GaggioliWellcome Trust/Cancer Research UK Gurdon Institute, 2 Department of Genetics, and 3 Department of Zoology, University of Cambridge, Cambridge CB2 1QN, England, UK.
Eva Zeiser
David Rivers
Charles R Bradshaw
Julie Ahringer
Philip Zegerman
Wellcome/Cancer Research UK Gurdon Institute · GBWellcome Trust · GBUniversity of Cambridge · GB

Funding

Cancer Research UK C6946/A14492Wellcome Trust 054523Wellcome Trust 092096Wellcome Trust 101863Worldwide Cancer Research 10-0908
6 · The paper itself

Abstract

Cyclin-dependent kinase (CDK) plays a vital role in proliferation control across eukaryotes. Despite this, how CDK mediates cell cycle and developmental transitions in metazoa is poorly understood. In this paper, we identify orthologues of Sld2, a CDK target that is important for DNA replication in yeast, and characterize SLD-2 in the nematode worm Caenorhabditis elegans. We demonstrate that SLD-2 is required for replication initiation and the nuclear retention of a critical component of the replicative helicase CDC-45 in embryos. SLD-2 is a CDK target in vivo, and phosphorylation regulates the interaction with another replication factor, MUS-101. By mutation of the CDK sites in sld-2, we show that CDK phosphorylation of SLD-2 is essential in C. elegans. Finally, using a phosphomimicking sld-2 mutant, we demonstrate that timely CDK phosphorylation of SLD-2 is an important control mechanism to allow normal proliferation in the germline. These results determine an essential function of CDK in metazoa and identify a developmental role for regulated SLD-2 phosphorylation.

Indexed as

DNA ReplicationAmino Acid SequenceAnimalsBlotting, WesternCaenorhabditis elegansCaenorhabditis elegans ProteinsCell ProliferationCyclin-Dependent KinasesEmbryo, NonmammalianFluorescent Antibody TechniqueGene Expression Regulation, DevelopmentalGerm CellsMolecular Sequence DataMutationPhosphorylationSequence Homology, Amino AcidCaenorhabditis elegans ProteinsCyclin-Dependent Kinases

Identifiers

PMID24535824
PMCPMC3926958
OpenAlexW2167965886

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.